What are the drug interactions between mirtazapine and diltiazem (calcium channel blocker) and digoxin (cardiac glycoside)?

Drug Interactions of Mirtazapine with Diltiazem and Digoxin

Mirtazapine can be safely combined with both diltiazem and digoxin without clinically significant pharmacokinetic interactions, but the combination of diltiazem and digoxin requires careful monitoring due to their well-established interaction.

Mirtazapine-Diltiazem Interaction

Mirtazapine is primarily metabolized by CYP2D6, CYP1A2, and CYP3A4. While diltiazem is a moderate CYP3A4 inhibitor 1, this interaction is not clinically significant for mirtazapine because:

• Mirtazapine has multiple metabolic pathways, reducing dependence on any single enzyme
• No dose adjustment of mirtazapine is typically required when combined with diltiazem
• Monitor for increased sedation or other mirtazapine side effects (increased appetite, weight gain) if they emerge, but this is uncommon

Mirtazapine-Digoxin Interaction

No clinically significant interaction exists between mirtazapine and digoxin. These medications can be safely co-administered without dose adjustments. Mirtazapine does not affect P-glycoprotein transport or renal clearance of digoxin.

Diltiazem-Digoxin Interaction: The Critical Concern

The combination of diltiazem and digoxin requires vigilant monitoring, as diltiazem increases digoxin levels by approximately 20-40%. 1, 2, 3

Mechanism

• Diltiazem inhibits P-glycoprotein, reducing renal and intestinal clearance of digoxin 4
• This interaction increases steady-state digoxin concentrations within 3-7 days 3
• The effect persists throughout concurrent therapy

Clinical Management Algorithm

When initiating diltiazem in a patient on digoxin:

1. Measure baseline digoxin level before starting diltiazem
2. Reduce digoxin dose by 25-30% prophylactically when adding diltiazem
3. Recheck digoxin level in 3-7 days after diltiazem initiation 3
4. Monitor for digoxin toxicity signs:
   • Bradycardia (heart rate <60 bpm)
   • Gastrointestinal symptoms (nausea, vomiting, anorexia)
   • Neuropsychological changes (confusion, visual disturbances)
   • Cardiac arrhythmias 5

When initiating digoxin in a patient on diltiazem:

1. Start with a lower initial digoxin dose (reduce by 25-30%)
2. Check digoxin level after reaching steady state (5-7 days)
3. Titrate based on clinical response and serum levels

Therapeutic Synergy vs. Toxicity Risk

The combination of diltiazem and digoxin is therapeutically beneficial for rate control in atrial fibrillation, as they work synergistically on the AV node 6, 7. Studies demonstrate:

• Superior rate control at rest and during exercise compared to either agent alone 7
• Diltiazem achieves rate control within 10 minutes vs. 352 minutes for digoxin alone 8, 9, 10
• Combined therapy allows lower doses of each drug, potentially reducing individual side effects

However, this combination increases risk of:

• Excessive bradycardia and heart block 2
• Digoxin toxicity from elevated levels 1, 3

Special Populations

Renal impairment: Exercise extreme caution, as both drugs are renally cleared. The interaction is magnified in patients with reduced kidney function. More aggressive digoxin dose reduction (40-50%) may be necessary 2.

Elderly patients: Higher risk for both digoxin toxicity and bradycardia. Start with lower doses and monitor more frequently 5.

Summary Recommendations

• Mirtazapine + Diltiazem: Safe combination, no dose adjustment needed
• Mirtazapine + Digoxin: Safe combination, no dose adjustment needed
• Diltiazem + Digoxin: Effective but requires proactive digoxin dose reduction (25-30%), serial digoxin level monitoring, and vigilance for toxicity signs

The primary clinical concern when prescribing all three medications together is the diltiazem-digoxin interaction, not any interaction involving mirtazapine.